Treatment charges and resource use among patients with heart failure enrolled in an MCO

Gregory de Lissovoy1, Marc Zodet, Karen Coyne

  • 1MEDTAP International, Bethesda, Maryland, USA.

Managed Care Interface
|May 25, 2002
PubMed

Insights

Hospital admission for heart failure (HF) significantly increases annual treatment costs by 98%. Expenditures rose substantially post-admission, regardless of patient age, highlighting the economic burden of HF care.

Area of Science:

  • Health Economics
  • Cardiology
  • Healthcare Management

Background:

  • Heart failure (HF) is a significant public health concern with substantial economic implications.
  • Understanding patient-level expenditures associated with HF is crucial for resource allocation and healthcare policy.

Purpose of the Study:

  • To determine patient-level annual expenditures and resource utilization for heart failure (HF).
  • To analyze the change in annual expenditure following a hospital admission for HF.

Main Methods:

  • Retrospective analysis of administrative claims data from 899 adult patients (40-74 years) continuously enrolled in an IPA-model MCO.
  • Data collected for the period 1996-1998, focusing on individuals with a primary HF diagnosis during index hospitalization.
  • Analysis stratified by age groups and pre-index expenditure quintiles.

Main Results:

  • Median annual charges increased by 98% (from $6,026 pre-event to $14,292 post-event) after HF hospitalization.
  • Mean annual charges saw a 105% increase post-event.
  • One-year readmission rates varied from 30% in the lowest expenditure quintile to 63% in the highest.
  • Expenditure and expenditure increase were not significantly related to patient age.

Conclusions:

  • Hospital admission for heart failure is associated with a significant rise in treatment intensity and annual healthcare expenditure.
  • While HF prevalence increases with age, patient-level treatment costs remain comparable across different age groups.
  • Healthcare systems should anticipate and plan for increased resource utilization following HF admissions.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...